Euro-Med Laboratories Phil., Inc. Declares Cash Dividend, Payable on 27 November 2023
October 25, 2023 at 05:42 am IST
Share
Board of Directors of Euro-Med Laboratories Phil., Inc. at its regular hyflex meeting held on 24 October 2023 approved the declaration of cash dividend in the amount of PHP 0.035 per share from the unrestricted retained earnings of the corporation as of 31 December 2022, to all stockholders of record as of 10 November 2023 and which shall be paid on 27 November 2023.
Euro-Med Laboratories Phil., Inc. is a Philippines-based company, which is engaged in the manufacturing of pharmaceutical products, such as large and small-volume parenteral and other solutions, inhalation, irrigation, and dialysis. It also manufactures sterile water for injection, and other solutions, such as ophthalmic, inhalation, irrigation and dialysis. The Company's segments include manufacturing pharmaceutical products, providing health and other care services, and development and operation of quick service restaurants. Its subsidiaries include Hemotek Renal Center, Inc. (Hemotek), and CafeFrance Corp (CafeFrance). Hemotek provides renal and other healthcare services and is engaged as a dialysis center. CafeFrance is engaged in the development and operation of quick service restaurant (QSR). CafeFrance is engaged in operating restaurants, bakeries, food services, catering, food production and other related services incidental thereto.